Effect of conversion from CCB to ARB in treatment of hypertension and proteinuria in kidney transplant recipients
10.3760/cma.j.issn.0254-1785.2011.11.004
- VernacularTitle:肾移植术后将CCB替换为ARB控制高血压和蛋白尿的效果
- Author:
Meisheng ZHOU
;
Liming WANG
;
Shu HAN
;
Shangxi FU
;
Wenyu ZHAO
;
Xueyang ZHENG
;
Li ZENG
;
Lei ZHANG
;
Youhua ZHU
- Publication Type:Journal Article
- Keywords:
Kidney transplantation;
Hypertension;
Proteinuria;
Calcium channel blockers;
Angiotensin receptors blockers
- From:
Chinese Journal of Organ Transplantation
2011;32(11):655-658
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the efficacy and safety of conversion from CCB to ARB in the treatment of hypertension and proteinuria in kidney transplant recipients.Methods 127 long-term recipients who used CCB as their anti-hypertensive drug were enrolled.All recipients had stable renal function and no diabetes.Recipients were randomly assigned to experimental group (65 cases) which received ARB (Losartan,50～ 100 mg/day) instead of CCB,or control group (62 cases) which received routine CCB.All recipients were followed up for 2 years.Blood count,urinalysis,liver and kidney chemistry,blood lipid,serum electrolytes,24-h urine protein,blood concentration of CNI drugs and other biochemical indexes were observed.Results During the 2-year follow-up,the blood pressure of the two groups was maintained within normal level.The 24-h urine protein was decreased in the experimental group ( 176.32 ± 54.54 to 155.69 ± 62.25,P＜0.05),but increased slightly in the control group (P＞0.05).Although the blood lipid of the experimental group was not different before and after the follow-up,the high density lipoprotein (HDL) was increased statistically (2.25 ± 0.26 to 2.46 ±0.31,P＜0.05).The blood count,liver and kidney chemistry,serum potassium,blood concentration of CNI drugs in both groups showed no significant differences.Conclusion Both CCB and ARB could be effectively and safely used for the treatment of hypertension and proteinuria in kidney transplant recipients.ARB would be more effective in reducing cardiovascular disease (CVD)rate and decreasing proteinuria.
